Omdia forecasts the global gaming peripherals and accessories market to exceed $20 billion by 2025, driven by high-end products like Sony's DualSense Edge controller. Growth will continue, reaching nearly $25 billion by 2030, with gaming monitors leading the charge.
Nestlé announced the immediate departure of CEO Laurent Freixe due to a violation of the company's code of conduct involving a relationship with a subordinate. Philipp Navratil, previously head of Nespresso, has taken over as CEO. The company's stock fell following the announcement.
Schall Law Firm is representing investors who lost money in Biohaven Ltd. (BHVN) stock between March 24, 2023, and May 14, 2025. The firm alleges Biohaven made misleading statements about its drug candidates. Investors who suffered losses are encouraged to contact the firm.
Electric Hydrogen has appointed Bruno Forget as its General Manager for Europe and the Middle East and North Africa (MENA). Forget will oversee Electric Hydrogen’s strategy and HYPRPlant delivery in the region, aiming to meet surging demand for large-scale, low-cost green hydrogen.
BioNxt Solutions Inc. (CSE: BNXT) announced it received the Semaglutide API, initiating lab-scale formulation and testing of its oral dissolvable film. The company is collaborating with Gen-Plus GmbH in Munich to develop this innovative delivery system for the widely used diabetes and obesity medication. Patent protection is anticipated in the coming quarter.
E3 Lithium (TSXV: ETL) announced the start of Phase 1 commissioning at its Clearwater project demonstration facility. This phase focuses on the direct lithium extraction (DLE) system and purification units, aiming to produce high-quality lithium chloride for battery-grade lithium carbonate. Initial brine introduction is complete.
Baseload Capital, a Swedish company, announced a strategic investment in Furusato Netsuden, a Japanese geothermal energy developer. This partnership aims to expand geothermal energy in Japan and create a sustainable energy model globally, focusing on community involvement.
Novaremed AG announced the completion of its NIH-funded Phase 2b trial for nispomeben in treating painful diabetic peripheral neuropathy (DPN). Topline results are expected in November 2025. The trial enrolled 127 adult and elderly patients.
Hilbert Group AB (Nasdaq:HILB B) announced the acquisition of Nordark, a rapidly expanding crypto banking platform. The deal, valued initially at 2,970,105 Hilbert B shares, positions Hilbert to significantly expand its digital finance offerings and revenue streams. The acquisition is expected to close by September 15th.
Cadeler, a global offshore wind installation firm, opened a larger Taipei office to support its growing Asia-Pacific operations. The expansion reflects Cadeler's commitment to the region's burgeoning offshore wind energy market and its strong project pipeline.
